Loading ...

Stock Quote bmy

bmy Stock Price Today

bmy Price History

bmy Stock Price History

bmy History

Last Price bmy

Close Price bmy

Day Change bmy

After Hours Quote bmy

Open Price bmy

Day Range bmy

Year Range bmy

Projected Yield bmy

Market Cap bmy

Stock Volume bmy

Average Volume bmy

Forward Price bmy

PE for bmy

PB for bmy

PS for bmy

PCF for bmy

price earnings ratio bmy

price to book ratio bmy

price to sales ratio bmy

price to cash flow ratio bmy

Stock Quote Bristol-Myers Squibb Company

Bristol-Myers Squibb Company Stock Price today

Bristol-Myers Squibb Company Price history

Bristol-Myers Squibb Company Stock Price history

Bristol-Myers Squibb Company history

Last Price Bristol-Myers Squibb Company

Close Price Bristol-Myers Squibb Company

Day Change Bristol-Myers Squibb Company

After Hours Quote for Bristol-Myers Squibb Company

Open Price Bristol-Myers Squibb Company

Day Range Bristol-Myers Squibb Company

Year Range Bristol-Myers Squibb Company

Projected Yield Bristol-Myers Squibb Company

Market Cap Bristol-Myers Squibb Company

Stock Volume Bristol-Myers Squibb Company

Average Volume Bristol-Myers Squibb Company

Forward Price Bristol-Myers Squibb Company

pe Bristol-Myers Squibb Company

pb Bristol-Myers Squibb Company

ps Bristol-Myers Squibb Company

pcf Bristol-Myers Squibb Company

price earnings ratio Bristol-Myers Squibb Company

price to book ratio Bristol-Myers Squibb Company

price to sales ratio Bristol-Myers Squibb Company

price to cash flow ratio Bristol-Myers Squibb Company

What Does This Company Do?
Bristol-Myers Squibb Co is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.
Sector
Healthcare
Industry
Drug Manufacturers - Major
Stock Type
Slow Growth
Employees
28000
Stock Style
Large Growth

Key Stats  BMY More...

Key Stats BMY

Morningstar Rating for XNYS:bmy Bristol-Myers Squibb Company - 2 stars.
Morningstar Ratings Expained

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

News  bmy - Bristol-Myers Squibb Company More...

Analyses from Phase IIIb Study Provide Additional Data in Earlier Use of Orencia (abatacept) Plus Methotrexate (MTX) in Citrullinated Protein (CCP)-Positive Adult Patients with Early Rheumatoid Arthritis (RA)
Bristol-Myers Squibb Announces Collaboration to Evaluate Opdivo (nivolumab) in Combination with Targeted Therapies from Novartis to Treat Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland
European Commission Approves Bristol-Myers Squibb’s Daklinza (daclatasvir) Across Multiple Genotypes for the Treatment of Chronic Hepatitis C Infection
Bristol-Myers Squibb Presents Data from Multiple New Studies at IDWeek 2014™ Showcasing Continued Innovation in Virology
Bristol-Myers Squibb Announces Multiple Regulatory Milestones for Opdivo (nivolumab) in the U.S. and European Union
Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma
Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support Cardiovascular Education for Patients and Caregivers
Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  bmy - Bristol-Myers Squibb Company More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports bmy - Bristol-Myers Squibb CompanyMore...

Click above to view more mutual fund data and stats for bmy - Bristol-Myers Squibb Company.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   BMY More ...

Ownership BMY

Vanguard Health Care Inv
VA CollegeAmerica Inc Fund of Amer 529E
Vanguard Total Stock Mkt Idx
SPDR® S&P 500 ETF
Vanguard 500 Index Inv
Stock Price Quote: bmy Bristol-Myers Squibb Company - XNYS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: bmy - Bristol-Myers Squibb Company  |  Next: bmy - Bristol-Myers Squibb Company